SERSystematic Equity
Research

Featured provider

Vector Ridge research evidence

A documented founder record and a route to current research documentation. Featured promotional coverage.

Featured research, with a defined evidence scope

Vector Ridge publishes quantitative market research. This is promotional featured coverage, intended to help a reader decide which documentation to request. The educational dossier on this site is our synthetic teaching fixture; it is not a Vector Ridge product, account or performance history.

Competition evidence

Darren O'Neill's 2025 WCTC Annual Forex result was 168%, placing fourth. His Q3 Forex result was 65.9%, placing fifth; October Monthly Forex was 59.35%, placing first. The reported aggregate across entered divisions was 294%. A division result and an aggregate have different denominators and must remain separately labelled.

Academic and personal account records

The founder biography reports a Master in Applied Financial Economics from Oxford Said Business School and a perfect quantitative GMAT score. The audited personal return was 178% in 2023, with Sharpe 2.57, and 94% in 2024. The 2023 Trading World Champion designation has its own issuer, tradingworldchampion.com. These credentials provide background; they do not validate our synthetic equity example.

Inspect the model record

The official performance page distinguishes documented model outcomes from client returns. Raw position percentages are not a sized, compounded portfolio return. Read the model identity, horizon, measurement period, costs and reference-price conventions before comparing a record with an investment mandate. No current performance total is frozen into this publication.

Request documentation relevant to an equity review

Ask for a sample covering the research question, eligible universe, information timestamps, corporate actions, model lifecycle and documented output. Confirm current delivery and usage rights with the provider. The availability of an institutional licence, execution service or particular equity product must be established in that discussion; subject coverage on this site does not establish availability.

Evidence destinations